A. Tienghi

Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

Stefano Ferrari, Sigbjørn Smeland, Mario Mercuri et al. · Journal of Clinical Oncology · 2005 · 432 citations

Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival

Stefano Ferrari, A Briccoli, Mario Mercuri et al. · Journal of Clinical Oncology · 2003 · 312 citations · Full text

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

Gaetano Bacci, Piero Picci, Stefano Ferrari et al. · Cancer · 1993 · 296 citations · Full text

Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities.

Piero Picci, Tom Böhling, G. Bacci et al. · Journal of Clinical Oncology · 1997 · 260 citations

Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.

G. Bacci, Stefano Ferrari, N. Delépine et al. · Journal of Clinical Oncology · 1998 · 144 citations